Leaderboard

En | De
Sie sind hier: Urologie-Nephrologie » Tumoren/BPH 19. April 2021
Suchen
medline.ch
Tumoren/BPH
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Entzündung-Infekt
Nephrolithiasis
Niereninsuffizienz
Sexualität
Tumoren/BPH
Anderes
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7106  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 142116  
   
Mapping evidence on the distribution of the costs associated with cancer of prostate, cervix, and female breast in the sub-Saharan Africa: protocol for a scoping review.
Syst Rev
Ngcamphalala C, Ostensson E, Hlongwa M, Ginindza TG.
PMID: 33863378 [PubMed - as supplied by publisher]


Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis.
BMC Cancer
Watanabe D, Kimura T, Watanabe K, Takano H, Uehara Y, Minowa T, Yamashita A, Yoshikawa S, Mizushima A.
PMID: 33863312 [PubMed - as supplied by publisher]


Radiomic profiling of clear cell renal cell carcinoma reveals subtypes with distinct prognoses and molecular pathways.
Transl Oncol
Lin P, Lin YQ, Gao RZ, Wen R, Qin H, He Y, Yang H.
PMID: 33862522 [PubMed - as supplied by publisher]


SPOP suppresses testicular germ cell tumors progression through ubiquitination and degradation of DPPA2.
Biochem Biophys Res Commun
Wang J, Zhuang H, Zhang H, Li Q, Cao X, Lin Z, Lin T, Chen X, Ni X, Yang J, Zhao Y, Shen L, Wang H, Zhu J, Ye M, Jin X.
PMID: 33862460 [PubMed - as supplied by publisher]


Circulating Tumor Cell Detection Methods in Renal Cell Carcinoma: A Systematic Review.
Crit Rev Oncol Hematol
Leitão TP, Miranda M, Polido J, Morais J, Corredeira P, Alves P, Oliveira T, E Silva RP, Fernandes R, Ferreira J, Reis JP, Lopes T, Costa L.
PMID: 33862248 [PubMed - as supplied by publisher]


Pelvic lymph node dissection in high-risk prostate cancer.
Int Braz J Urol
Haiquel L, Cathelineau X, Sanchez-Salas R, Macek P, Secin F.
PMID: 33861538 [PubMed - as supplied by publisher]


Bricker ileal conduit vs. Cutaneous ureterostomy after radical cystectomy for bladder cancer: a systematic review.
Int Braz J Urol
Korkes F, Fernandes E, Gushiken FA, Glina FPA, Baccaglini W, Timóteo F, Glina S.
PMID: 33861058 [PubMed - as supplied by publisher]


Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates.
Asia Pac J Clin Oncol
Poon DM, Chan CK, Chan TW, Cheung FY, Ho LY, Kwong PW, Lee EK, Leung AK, Leung SY, So HS, Tam PC, Ma WK.
PMID: 33860645 [PubMed - in process]


Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology 2019.
Asia Pac J Clin Oncol
Poon DM, Chan CK, Chan K, Chu WH, Kwong PW, Lam W, Law KS, Lee EK, Liu PL, Sze HC, Wong JH, Chan ES.
PMID: 33860644 [PubMed - in process]


Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology.
Asia Pac J Clin Oncol
Poon DM, Chan CK, Chan TW, Cheung FY, Ho LY, Kwong PW, Lee EK, Leung AK, Leung SY, So HS, Tam PC, Ma WK.
PMID: 33860643 [PubMed - in process]


Brain Boron Level, DNA Content, and Myeloperoxidase Activity of Metformin-Treated Rats in Diabetes and Prostate Cancer Model.
Biol Trace Elem Res
Ozel AB, Dagsuyu E, Ayd, Bugan I, Bulan OK, Yanardag R, Yarat A.
PMID: 33860456 [PubMed - as supplied by publisher]


Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020.
Prostate Cancer Prostatic Dis
Lythgoe MP, Krell J, Savage P, Prasad V.
PMID: 33859363 [PubMed - as supplied by publisher]


Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
BMC Cancer
Fei H, Chen S, Xu C.
PMID: 33858375 [PubMed - in process]


Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
Technol Cancer Res Treat
Su Y, Zhou L, Yu Q, Lu J, Liu W.
PMID: 33858283 [PubMed - in process]


Diagnostic significance of stromal changes in biopsies of prostate adenocarcinoma.
Pathol Res Pract
Dzaparidze G, Kazachonok D, Gvozdkov A, Taelma H, Laht K, Minajeva A.
PMID: 33857855 [PubMed - as supplied by publisher]


Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials.
Pathol Res Pract
Rizzo A, Mollica V, Rosellini M, Marchetti A, Ricci AD, Fiorentino M, Battelli N, Santoni M, Massari F.
PMID: 33857854 [PubMed - as supplied by publisher]


Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries.
JCO Glob Oncol
Monteiro FSM, Schutz FA, Morbeck IAP, Bastos DA, de Padua FV, Costa LAGA, Maia MC, Rinck JA Jr, Zequi SC, da Trindade KM, Alfer W Jr, Nahas WC, Dos Santos LV, Ferrigno R, da Rosa DAR, Sade JP, Orlandi FJ, de Oliveira FNG, Soares A.
PMID: 33856897 [PubMed - in process]


Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
JCO Glob Oncol
Maluf FC, Pereira FMT, Serrano Uson PL Jr, Bastos DA, Rodrigues da Rosa DA, Wiermann EG, Schutz FA, Kater FR, de Oliveira FNG, Marques Monteiro FS, de Pádua FV, Orlandi FJ, de Almeida Saito HP, Ayadi M, Boghikian PS, Kopp RM, de Carvalho RS, de Fogace RN, de Araújo Cavallero SR, Aguiar S, Souza VC, Sommer SG.
PMID: 33856896 [PubMed - in process]


Consensus on Screening, Diagnosis, and Staging Tools for Prostate Cancer in Developing Countries: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
JCO Glob Oncol
Carneiro A, Racy D, Bacchi CE, Leite KRM, Filippi RZ, Martins IAF, Salvajoli JV, Hanriot RM, Baroni RH, Sarkis AS, Pompeo ACL, Benigno BS, Guimarães GC, Aldousari S, Nardi AC, Pompeo ASFL, Nowier A, Nardozza A Jr, Adamy A Jr, Freitas CH Jr, Chade DC, Otero DAC, Neto DCVDS, Carvalhal EF, Korkes F, Ferrigno R.
PMID: 33856895 [PubMed - in process]


Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
JCO Glob Oncol
Luz MA, Guimarães GC, Nardi AC, Pompeo ASFL, Sarkis ÁS, Nowier A, Lima Pompeo AC, Nardozza A Jr, Adamy A Jr, Carneiro A, Salvajoli BP, Benigno BS, Freitas CH Jr, Chade CADC, Palhares DMF, Otero DAC, Neto DCVDS, Carvalhal EF, Gil E, Freire de Arruda F, Korkes F, Caserta Lemos G, Carvalhal GF, de Carvalho ÍT, Gimpel IFP, Chambô JL, Pontes J Jr, Filho LAR, Nogueira LM, Wroclawski ML, Freitas MRP, Arap MA, Sadi MV, Bulbul M, Coelho RF, Gadia R, Khauli RB, Dos Reis RB, Rojas RAL, Guimarães RG, Aldousari S, Ferrigno R.
PMID: 33856894 [PubMed - in process]


   
   Artikel 1 - 20 / 142116    Seite 1 von 7106  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

  Zeitfenster  
   

Sky right 1